ACTRN12612001098820已完成未知
Prospective, controlled, open label, bilateral, clinical trial to investigate daily, morning cleaning of silicone hydrogel contact lenses worn during extended wear as a strategy for reducing adverse events associated with contact lens wear in neophyte and experienced lens wearers
Brien Holden Vision Institute0 个研究点目标入组 200 人开始时间: 2012年10月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit(—)
- 性别
- All
入选标准
- •Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent.
- •-Be at least 18 years old, male or female.
- •-Be willing to comply with the wearing and clinical trial visit schedule as directed by the Investigator.
- •-Have ocular health findings considered to be normal” and which would not prevent the participant from safely wearing contact lenses.
- •-Have vision that is correctable to at least 6/12 (20/40) or better in each eye with contact lenses/spectacles.
- •-Be experienced or inexperienced at wearing contact lenses.
排除标准
- •-Any pre-existing ocular irritation, injury or condition (including keratoconus and herpes keratitis) of the cornea, conjunctiva or eyelids that would preclude contact lens fitting and safe wearing of contact lenses;
- •-Any systemic disease that adversely affects ocular health e.g. diabetes, Graves disease, and auto-immune diseases such as ankylosing spondylitis, multiple sclerosis, Sjögrens syndrome and systemic lupus erythematosis. Conditions such as systemic hypertension and arthritis do not automatically exclude prospective participants;
- •-An active corneal infection or any active ocular disease that would affect wearing of contact lenses;
- •-Use of or a need for any therapeutic ocular medication up to 4 weeks prior to and during the trial;
- •-Use of or a need for any systemic medication or topical medications which may alter normal ocular findings/are known to affect a participant’s ocular health/physiology or contact lens performance either in an adverse manner or risk providing a false positive.
- •-Eye surgery within 12 weeks immediately prior to enrolment for this trial.
- •-Previous corneal refractive surgery.
- •-Contraindications to contact lens wear.
- •-Known allergy or intolerance to ingredients in any of the clinical trial products.
- •-Currently enrolled in another clinical trial.
研究者
相似试验
已完成
不适用
Evaluation of tear lipid changes during daily wear of silicone hydrogel lenses and use of two lens disinfection solutions in 30 new and experienced contact lens wearing participants.Contact Lens WearEye - Normal eye development and functionACTRN12608000609358Institute for Eye Research30
已完成
4 期
Bioavailability study of Curcuminoids capsules of Triokka Pharmaceuticals Private Limited, India with Meriva-SR of Throne Research Inc., USA in 8 Healthy adult human male subjects under fasting conditions.CTRI/2016/05/006938Troikaa Pharmaceuticals Limited8
尚未招募
不适用
Study to compare the safety, tolerability and effectiveness of topical Minoxidil 5% solution in Indian male patients with mild to moderate pattern hair lossCTRI/2021/09/036777Hairrevive Centre for Hair Restoration Skin Rejuvenation
已完成
不适用
Bacterial contamination of antibacterial contact lens cases during daily wear of marketed contact lensesACTRN12609000165280Institute for Eye Research40
已完成
不适用
CLBS12-P01Patients with critical limb ischemia (CLI) due to arteriosclerosis obliterans (ASO) and patients with CLI due to Buerger's Disease (BD)JPRN-jRCT1080223694EPS Corporation (Global Sponsor: Caladrius Biosciences, Inc.)35
